Zera Health review
The opening figure carries a dose qualifier the seller states itself.
The verdict
Zera Health advertises $129 a month for semaglutide, and describes that line as a low-dose weekly injection rather than as its standing rate. The tablet is $169 and tirzepatide $199.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection · Oral
- Dose pricing
- Flat across doses
- States
- 50
- Injection
- From $129/mo
- Oral
- From $169/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Zera Health sells compounded semaglutide and compounded tirzepatide through an online service covering all fifty states. The semaglutide injection is $129 a month and is described by the seller as low-dose. A daily dissolving tablet is $169. Injectable tirzepatide is $199. All three are stated as flat across doses.
Who writes the prescription, and what do they see?
Treatment is arranged remotely and a prescription is issued before shipping. The product pages carry the rate and a one-line description of the form. They do not describe the clinician or what the intake asks.
The service runs at a distance and every product is compounded. The useful detail is the qualifier on its opening line. A seller that writes low-dose beside its opening figure has told the reader something most leave to be discovered. The rest of this assessment rests on that being accurate.
What happens when the dose goes up?
All three rates are stated as flat across doses. That claim sits oddly beside a line described as low-dose. The two are worth reconciling at the intake. A flat rate on a low-dose product may mean it holds within that tier rather than across the ladder.
What the price includes
At $129 the semaglutide is a low figure, and the qualifier is what makes it readable rather than misleading. A reader who escalates past the low-dose tier should establish what they will be charged then, because the page does not carry a ladder. The $70 step from injection to tablet is wider than several sellers charge, and the $70 step from semaglutide to tirzepatide is narrower.
What it claims, and what it cites
Both molecules are compounded, prepared by a pharmacy rather than manufactured and reviewed as finished products. Neither is FDA-approved and neither is assessed for safety, efficacy or quality before dispensing. The trial evidence quoted for these drugs came from the approved products at labeled doses.
Where it holds up, and where it does not
- Strength: The dose qualifier is stated, not buried
- Strength: All fifty states served
- Strength: Narrow step between the two molecules
- Limitation: The opening line is not the standing rate
- Limitation: No dose ladder is published
- Limitation: Flat-rate claim sits oddly beside a low-dose line
What the evidence says about this kind of treatment
The assessment above is about Zera Health. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who reads the qualifier before the figure, since the $129 line is described as low-dose.
- Wrong for
- A reader expecting $129 to be what a maintenance dose costs, which the seller does not say.
How Zera Health compares
| Seller | Who it suits | Go |
|---|---|---|
| Alan Meds | A reader starting on injectable semaglutide who wants a low rate that is stated to hold as the dose climbs. | See Alan Meds → |
| DoctorAdam | A reader weighing a tablet against an injection who wants the decision to be about the routine rather than the cost. | See DoctorAdam → |
 Revel Health | A reader who wants an oral and expects to pay less for it, which on this seller is what happens. | See Revel Health → |
More GLP-1 telehealth sellers reviews: Lean MedsLibertyMaximusNextMedsNovaPallas Health
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- Is $129 what I would pay at any dose?
- Zera describes that line as a low-dose weekly injection and separately states its rates are flat. Those two claims need reconciling at the intake before you rely on either.
- Why is the tablet more than the injection?
- That is how Zera prices it: $169 for the daily dissolving tablet against $129 for the weekly injection.
- Does Zera serve my state?
- All fifty are listed.
- Is Zera Health expensive compared with other GLP-1 telehealth sellers?
- Zera Health publishes a starting figure of $129/mo. Across the 32 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $299 with a median of $139, which puts Zera Health below the median, toward the cheaper end. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.